Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Study Comparing AVD Combined With Fixed-Dose Nivolumab Versus PET-Adapted BEACOPP-like Regimen as First-Line Treatment in Advanced Classical Hodgkin Lymphoma

NCT07234487 is registered in ClinicalTrials.gov with St. Petersburg State Pavlov Medical University as lead sponsor.

NCT NCT07234487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07234487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Study Comparing AVD Combined With Fixed-Dose Nivolumab Versus PET-Adapted BEACOPP-like Regimen as First-Line Treatment in Advanced Classical Hodgkin Lymphoma
Lead sponsor
St. Petersburg State Pavlov Medical University
Phase
Phase 2
Overall status
Recruiting
Start date
October 14, 2024
Completion date
October 31, 2030
Enrollment
178 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin lymphoma